Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-04-10
2007-04-10
Padmanabhan, Sreenivasan (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S449000, C514S730000, C514S731000
Reexamination Certificate
active
10176762
ABSTRACT:
Therapeutic methods of treatment, compositions and foodstuffs are described which contain isoflavone compounds described by general formula (1), in which Z is H, R1is H, or RACO where RAis C1-10alkyl or an amino acid, R2is H, OH, or ORBwhere RBis an amino acid, or CORA where RAis as previously defined, W is H, A is H or OH, and B is selected from (a), (b), (c), or W is H, and A and B taken together form a six-membered ring selected from (d), or W, A and B taken with the groups with which they are associated comprise (e), or W and A taken together with the groups with which they are associated comprise (f) and B is (g) wherein R3is H, CORAwhere RAis as previously defined, CO2Rcwhere RCis C1-10alkyl, or CORBwhere RBis as previously defined, R4is H, CORDwhere RDis H, OH, C1-10alkyl or an amino acid, CO2RCwhere RCis as previously defined, COREwhere REis H, C1-10alkyl or an amino acid, COOH, CORCwhere RCis as previously defined, or CONHREwhere REis as previously defined, R5is H, CORCwhere RCis as previously defined, or CORCOREwhere RCand REare as previously defined, and where the two R5groups are attached to the same group they are the same or different, R6is H or hydroxy C1-10alkyl, X is preferably O, but may be N or S, and Y is (h) where R7is H, or C1-10alkyl
REFERENCES:
patent: 3471520 (1969-10-01), Imscher et al.
patent: 3535344 (1970-10-01), Imscher et al.
patent: 3886278 (1975-05-01), Gallo
patent: 3973608 (1976-08-01), Umezawa et al.
patent: 4061779 (1977-12-01), Lake et al.
patent: 4157984 (1979-06-01), Zilliken
patent: 4200692 (1980-04-01), Puls et al.
patent: 4264509 (1981-04-01), Zilliken
patent: 4301251 (1981-11-01), Rumyantseva et al.
patent: 4366082 (1982-12-01), Zilliken
patent: 4390559 (1983-06-01), Zilliken
patent: 4428876 (1984-01-01), Iwamura
patent: 4484013 (1984-11-01), Schmidt
patent: 4814346 (1989-03-01), Albert et al.
patent: 4950475 (1990-08-01), Vishnupad et al.
patent: 5141746 (1992-08-01), Fleury et al.
patent: 5153230 (1992-10-01), Jaffery
patent: 5247102 (1993-09-01), Kállay et al.
patent: 5320949 (1994-06-01), Shen
patent: 5352384 (1994-10-01), Shen
patent: 5424331 (1995-06-01), Shlyankevich
patent: 5489524 (1996-02-01), Resnick et al.
patent: 5498631 (1996-03-01), Gorbach et al.
patent: 5506211 (1996-04-01), Barnes et al.
patent: 5516528 (1996-05-01), Hughes et al.
patent: 5523087 (1996-06-01), Shlyankevich
patent: 5530112 (1996-06-01), Greenshields et al.
patent: 5547866 (1996-08-01), Durzan et al.
patent: 5554519 (1996-09-01), Weber et al.
patent: 5569459 (1996-10-01), Shlyankevich
patent: 5637561 (1997-06-01), Shen et al.
patent: 5637598 (1997-06-01), Grese
patent: 5639785 (1997-06-01), Kung
patent: 5679806 (1997-10-01), Zheng et al.
patent: 5700669 (1997-12-01), Hanson et al.
patent: 5702752 (1997-12-01), Gugger et al.
patent: 5726034 (1998-03-01), Bryan et al.
patent: 5733926 (1998-03-01), Gorbach
patent: 5763389 (1998-06-01), Shen et al.
patent: 5789581 (1998-08-01), Matsuura et al.
patent: 5792503 (1998-08-01), Gugger et al.
patent: 5804234 (1998-09-01), Suh et al.
patent: 5830887 (1998-11-01), Kelly
patent: 5855892 (1999-01-01), Potter et al.
patent: 5942539 (1999-08-01), Hughes, Jr. et al.
patent: 6004558 (1999-12-01), Thurn et al.
patent: 6060070 (2000-05-01), Gorbach
patent: 6146668 (2000-11-01), Kelly et al.
patent: 6235773 (2001-05-01), Bissett
patent: 6261565 (2001-07-01), Empie et al.
patent: 6340703 (2002-01-01), Kelly
patent: 6455032 (2002-09-01), Kelly et al.
patent: 6497906 (2002-12-01), Kelly
patent: 6562380 (2003-05-01), Kelly
patent: 6599536 (2003-07-01), Kelly et al.
patent: 6642212 (2003-11-01), Kelly
patent: 6649648 (2003-11-01), Kelly et al.
patent: 2002/0035074 (2002-03-01), Kelly
patent: B-80655/87 (1988-05-01), None
patent: A-10227/95 (1995-07-01), None
patent: A-24813/97 (1997-12-01), None
patent: A-73072/98 (1999-09-01), None
patent: A-27714/00 (2000-11-01), None
patent: 4432947 (1996-03-01), None
patent: 0129667 (1985-01-01), None
patent: 0135172 (1985-03-01), None
patent: 0136569 (1985-04-01), None
patent: 0426998 (1991-05-01), None
patent: 0 671 170 (1995-09-01), None
patent: 0 795 553 (1997-09-01), None
patent: 0 906 761 (1999-04-01), None
patent: 2 693 724 (1994-01-01), None
patent: 1482238 (1977-08-01), None
patent: 1 495 189 (1977-12-01), None
patent: S50-0035393 (1975-04-01), None
patent: S50-101360 (1975-08-01), None
patent: S50-160483 (1975-12-01), None
patent: 61-246124 (1986-11-01), None
patent: 61-246124 (1986-11-01), None
patent: 61-247396 (1986-11-01), None
patent: 02-67218 (1987-03-01), None
patent: 62-106016 (1987-05-01), None
patent: 62-106017 (1987-05-01), None
patent: 62-126186 (1987-06-01), None
patent: H01-042427 (1989-02-01), None
patent: H01-226824 (1989-09-01), None
patent: 01-258669 (1989-10-01), None
patent: 1-258669 (1989-10-01), None
patent: 02-069165 (1990-03-01), None
patent: H02-124883 (1990-05-01), None
patent: H02-160722 (1990-06-01), None
patent: 03-047049 (1991-02-01), None
patent: 05-170756 (1993-07-01), None
patent: H06-040876 (1994-02-01), None
patent: H06-040909 (1994-02-01), None
patent: H06-086682 (1994-03-01), None
patent: H06-321752 (1994-11-01), None
patent: 07-173148 (1995-07-01), None
patent: H09-067362 (1997-03-01), None
patent: H10-059956 (1998-03-01), None
patent: WO 91/14429 (1991-10-01), None
patent: WO 93/23069 (1993-11-01), None
patent: WO 94/23716 (1994-10-01), None
patent: WO 95/03293 (1995-02-01), None
patent: WO 96/10341 (1996-04-01), None
patent: WO 97/06273 (1997-02-01), None
patent: WO 97/46208 (1997-12-01), None
patent: WO 98/08503 (1998-03-01), None
patent: WO 98/48790 (1998-11-01), None
patent: WO 98/49153 (1998-11-01), None
patent: WO 98/52546 (1998-11-01), None
patent: WO 98/56373 (1998-12-01), None
patent: WO 99/11260 (1999-03-01), None
patent: WO 99/11263 (1999-03-01), None
patent: WO 99/18927 (1999-04-01), None
patent: WO 99/36050 (1999-07-01), None
patent: WO 99/37633 (1999-07-01), None
patent: WO 99/43335 (1999-09-01), None
patent: WO 00/03707 (2000-01-01), None
patent: WO 00/16759 (2000-03-01), None
patent: WO 00/54753 (2000-09-01), None
patent: WO 00/62765 (2000-10-01), None
patent: WO 00/64438 (2000-11-01), None
patent: WO 00/66576 (2000-11-01), None
Liepa. A Synthesis of Hydroxylated Isoflavylium Salts and Their Reduction Products. Australian Journal of Chemistry 1981, 34(12), pp. 2647-2655.
Wani et al. Flavonoids.8.Synthesis and Antifertility and Estrogen Receptor Binding Activities of Courmarins and 3-isoflavenes. Journal of Medicinal Chemistry, 1975, vol. 18, No. 10. pp. 982-985.
U.S. Appl. No. 08/049,006, filed 1993, Gorbach et al.
Adlercreutz, H. et al., “Determination of Urinary Lignans and Phytoestrogen Metabolites, Potential Antiestrogens and Anticarcinogens, in Urine of Women on Various Habitual Diets,”J. Steroid Biochem, vol. 25, No. 58, pp. 791-797 (1986).
Adlercreutz, Herman et al., “Dietary Phytoestrogens and Cancer:In VitroandIn VivoStudies,”J. Steroid Biochem Molec. Biol., vol. 41, No. 3-8 pp. 331-337 (1992).
Adlercreutz, Herman et al., “Dietary phyto-oestrogens and the menopause in Japan,”The Lancet, pp. 1233 (1992).
Adlercreutz, H. et al., “Excretion of the Lignans Enterolactone and Enterodiol and of Equol in Omnivorous and Vegetarian Postmenopausal Women and in Women with Breast Cancer,”The Lancet, pp. 1295-1299 (1982).
Adlercreutz, H. et al., “Lignans and Phytoesrogens”,Front. Gastrointest. Res., vol. 14, pp. 165-176 (1988).
Adlercreutz, Herman et al., “Urinary Excretion of Lignans and Isoflavoinoids Phytoestrogens in Japanese Men and Women Consuming a Traditional Japanese Diet,”Am. J. Clin. Nutr., vol. 54, pp. 1093-1100 (1991).
Adlercreutz, Herman, “Western Diet and Wester Diseases: Some Hormonal and Biochemical Mechanisms and Associations,”Scand. J. Clin. Lab. Invest, Suppl., vol. 201 pp. 3-23 (1990).
Anderson M.D., James et al., “Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids,”New Eng. J. Med., vol. 333, No. 5, pp. 276-282 (1995).
Barnes, Stephen et al., “Soybeans Inhibit Mammary Tu
Joannou George Eustace
Kelly Graham Edmund
Finnegan Henderson Farabow Garrett & Dunner LLP
Kim Jennifer
Novogen Research Pty Ltd
Padmanabhan Sreenivasan
LandOfFree
Therapeutic methods and compositions involving isoflavones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic methods and compositions involving isoflavones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic methods and compositions involving isoflavones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3796166